Apo ai polypeptides, antibodies, and immunoassays
CA 2084677 C · Owner: The Scripps Research Institute · Inventors: Bonnet, David J.; Banka, Carole L.; Curtiss, Linda K.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention describes an Apo AI polypeptide capable of immunologically mimicking an Apo AI epitope. The polypeptide is useful in diagnostic methods and systems for detecting Apo AI in vascular fluid samples, and for preparation of anti-Apo AI antibodies. In addition, the polypeptide is useful in therapeutic methods for increasing esterified cholesterol in a human patient.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 7, 1991 and granted November 4, 2003. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 7, 2011.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 7, 2013.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.